WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) will participate in the Cowen & Company 27th Annual Healthcare Conference on Thursday, March 15, 2007 in Boston. The Company’s President and CEO, Steven Rauscher, will provide an overview of the Company including details on the recent Canadian launch of FACTIVE® (gemifloxacin mesylate) tablets by Abbott Canada and the market performance of ANTARA® (fenofibrate) capsules and FACTIVE in the U.S.
